Dr Danijela Tatovic



Prosiectau fel Prif Ymchwiliwr

Microneedle technology to deliver peptide immunotherapy for type 1 diabetes - Cyllidwr:The Novo Nordisk UK Research Foundation (01.08.2011 - 31.08.2015)
A new window into the immune response funding during Type 1 Diabetes - Cyllidwr:Wellcome Trust (01.11.2017 - 31.05.2019)
Bringing immunotherapy for type 1 diabetes into the clinic: New windows into the immune response - Cyllidwr:Diabetes Research & Wellness Foundation (01.05.2018 - 30.04.2019)
Single cell analysis of disease-specific T-cells in Type 1 diabetes - Cyllidwr:Association of Physicians of GB & Ireland (06.01.2020 - 30.06.2021)


Prosiectau fel Cyd-Ymchwiliwr

Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger smarter faster - Cyllidwr:Juvenile Diabetic Research Foundation (01.05.2019 - 30.04.2022)
Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger smarter faster - Cyllidwr:Juvenile Diabetic Research Foundation, - Cyllidwr:Diabetes UK (01.05.2019 - 30.04.2022)

Diweddarwyd y tro diwethaf ar 2020-20-09 am 04:12